Sanofi Slams Mylan's 'Mishmash' Of Claims Over Insulin

By Carla Baranauckas · September 18, 2023, 4:54 PM EDT

Sanofi-Aventis U.S. is asking a Pennsylvania federal court to toss Mylan Pharmaceuticals' claims that Sanofi abused discounts and patent litigation to keep Mylan's generic injectable insulin off the market, arguing Mylan's...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

MYLAN PHARMACEUTICALS INC. et al v. SANOFI-AVENTIS U.S. LLC et al

Case Number

2:23-cv-00836

Court

Pennsylvania Western

Nature of Suit

Anti-Trust

Date Filed

May 18, 2023